CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Regenerex Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Regenerex Pharma Inc
5348 VEGAS DRIVE, SUITE 177
Phone: (305) 927-5191p:305 927-5191 LAS VEGAS, NV  89108  United States Ticker: RGPXRGPX
Business Summary
Regenerex Pharma, Inc. is engaged in developing and marketing woundcare healing products. The Company has three technologies for different types of wound conditions; first is for closing chronic wounds; second is for accelerating closure of acute or surgical wounds, and third solves the issue on contamination of all types of wounds including the destruction of biofilms. The Company's product includes Xcellderma OTC, Accelerex Sterile Wound Cream, and Accelerex Impregnated Sterile Wound Dressing. Xcellderma OTC is a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds. Accelerex is a custom-designed, unit-dose, sterile wound dressing impregnated with an ointment containing QBx. Accelerex Impregnated Sterile Wound Dressing is used as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
7389 Business services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Gregory P.Pilant 66
Chief Financial Officer, Treasurer, Secretary, Director DeborahPilant 70
Chief Operating Officer TroyThuet 61
Chief Research and Development officer LeeOri 47 1/1/2023 1/1/2023

Business Names
Business Name
Creenergy Corporation
Online Original Inc
ONLINE ORIGINALS, INC
Online Originals, Inc.
PEPT
RGPX

General Information
Outstanding Shares: 277,995,910 (As of 2/5/2024)
Shareholders: 211
Stock Exchange: OTC
Federal Tax Id: 980479983


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 16, 2024